Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Practical aspects of discovery pathology.

Toxicologic pathology - 1 Jan 2000

Burkhardt John E, Ryan Anne M, Germann Paul-Georg

Abstract excerpt

Pathologists are uniquely qualified to play a central role in driving drug discovery and development programs by: 1) establishing disease models to assess potential therapies, 2) characterizing modifications in the disease state in response to therapies, 3) characterizing toxicologic mechanisms and responses to drug candidates, and 4) facilitating multidisciplinary efforts to monitor for the clinical occurrence,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 4-Quinolones
Share to Angiogenesis Inhibitors
Share to Anti-Infective Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endothelial Growth Factors

Share to Haplorhini

Share to Lymphokines

Share to Rats, Inbred BN

Share to Vascular Endothelial Growth Factors

Source

Identifiers

PMID: 11890479
DOI: 10.1080/01926230252824653

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Practical aspects of discovery pathology.PMID 11890479Read ↗

Importance and impact of discovery pathology.Semantic proximity Read ↗

Finding a Place for New Approach Methodologies (NAMs) in Biomedical ResearchSemantic proximity Read ↗

Pathology: Cause and effect.Semantic proximity Read ↗

ANIMAL MODELS OF HUMAN DISEASE IN DRUG SAFETY ASSESSMENTSemantic proximity Read ↗

Molecular annotation of AOPs guides the development of the next generation mechanistic chemical safety assessment and new approach methodsSemantic proximity Read ↗

Drug discovery and repurposing at Memorial Sloan Kettering Cancer Center: chemical biology drives translational medicine.Semantic proximity Read ↗

The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.Semantic proximity Read ↗

Enrichment analysis for discovering biological associations in phenotypic screens.Semantic proximity Read ↗

Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways.Semantic proximity Read ↗

The program for phenotyping of genetically modified animals at AstraZeneca.Semantic proximity Read ↗

Establishment of a longitudinally tractable mouse model of cholestatic liver injury via drinking water administration of MDASemantic proximity Read ↗

Show and tell: disclosure and data sharing in experimental pathology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.